Many
of our recently held briefings are available on audiocassette files.
Visit our Tapes Library for our highly regarded series
on:
|
Audio
Library
FDA
Enforcement: FDA's New Warnings: Bark, Bite ...
or Both? |
| Speaker: |
Daniel
Michels of KMI/PAREXEL |
| Date
of Briefing: |
December
17 , 2003 |
| Approximate
length: |
One
hour |
| Description: |
The
FDA regulatory pendulum continues to swing,
but in what direction? Recent regulatory actions
may be signaling a harder enforcement program
at FDA, according to compliance expert Daniel
Michels of KMI/PAREXEL. “FDA is not
issuing as many warnings as in the past,”
says Michels, “ but final actions are
becoming more severe, particularly financially.”
If you or your clients are responsible for
responding to FDA-483s, warning letters, or
other FDA notices, you need to participate
in this informative discussion. |
| Price: |
$295
CD |
| ttttttttttttt
|
Go
to the
Order Form |
 |
Audio
Library
FDA
Enforcement: Preparing
Effective Investigative Reports
|
|
| Speakers: |
C.
Russ Rutledge, Senior COPnsultant, AAC Consulting Group
(former FDA official) |
| Date
of Briefing: |
September
18, 2003 |
| Approximate
length: |
One
hour |
| Description: |
FDA
investigators view reports for out-of-specification (OOS)
results, deviations, and batch failures as primary tools
for gathering information. They also bring varying degrees
of experience to an inspection...and they rely on first
impressions. Accordingly, it is incumbent upon the industry
to prepare reports that demonstrate control over operations,
generate few if any questions, and generally accelerate
the inspection process. Our presenter, C. Russ Rutledge
-- who wrote the 1998 draft guidance on handling OOS results
(that were never finalized) -- says that perceived pressure
by regulators is causing many firms to prepare overly
detailed standard operating procedures (SOPs). A better
alternative is to develop clear, legible failure investigation
procedures that specify an orderly sequence, including
flow charts and check lists. |
| Price: |
$275
Tape |
| ttttttttttttt
|
Go
to the
Order Form |
Audio
Library
FDA
Enforcement: Understanding
REACH |
|
| Speaker: |
Ansis
M. Helmanis, Barnes, Richardson & Colburn |
| Date
of Briefing: |
August
26, 2003 |
| Approximate
length: |
One
hour |
| Description: |
This
presentation covers REACH - "The Regulation,
Evaluation, and Authorization of Chemicals"
- and why it is important. Our presenter will encourage
the drug industry to influence the final version
of REACH. |
| Price: |
$195
Tape |
| ptovvvvv |
Go
to the
Order Form |
|
 |
Audio
Library
FDA
Enforcement: How Foreign Firms Can Avoid Warning
Letters and Import Detentions |
|
|
Speaker: |
Larry
R. Pilot, Esq. Partner, McKenna Long & Aldridge
(and former FDA official)
|
| Date
of Briefing: |
August
11, 2003 |
| Approximate
length: |
One
hour |
|
Description: |
The 30-year history of FDA
foreign inspections and issuance of Warning Letters demonstrates
what noted food and drug attorney Larry Pilot calls a
“remarkable bias” against foreign manufacturers,
including those owned and/or managed by U.S.-based companies.
The situation regarding device makers, in particular,
was revealed three years ago at a EUCOMED conference but
little has changed since. As progress is made toward global
harmonization, our presenter – a former FDA official
and an expert on product importation – makes a strong
case for establishing a level playing field for all manufacturers
while maintaining the quality and safety implicit in good
manufacturing practice (GMP) evaluation. |
| Price: |
$195
CD |
| ttttttttttttt
|
Go
to the
Order Form |
 |
Audio
Library
FDA
Enforcement: Impact of GMP's for Dietary Supplements |
|
| Speaker: |
D.
Watts
|
| Date
of Briefing: |
April
24, 2003 |
| Approximate
length: |
One
hour |
|
Description: |
This
audiobriefing features a specialist on dietary
supplements from the law firm of Sidley, Austin,
Brown & Wood. Watts describes the far reaching
impact the new FDA rules will have on how dietary
supplements are manufactured and packaged. This
includes most contractors and foreign suppliers. |
| Price: |
$195
CD |
| ttttttttttttt
|
Go
to the
Order Form |
 |
Audio
Library
FDA
Enforcement: Implement Corporate Coimpliance
Programs |
|
| Speaker: |
D.
Farquhar / J. Fleder
|
| Date
of Briefing: |
February
18, 2003 |
| Approximate
length: |
90
minutes |
|
Description: |
This
audiobriefing features two specialists on corporate
compliance with FDA regulations. They provide practical
information on how to set up effective compliance
programs that include training to help staff implement
the programs. They also discuss the pros and cons
of making voluntary disclosures, the timing of such
disclosures, and the person who should make the
disclosures. |
| Price: |
$195
CD |
| ttttttttttttt
|
Go
to the
Order Form |
 |
|
Audio
Library
FDA
Enforcement: How to Respond to FDA 483s and Warning
Letters |
|
| Speaker: |
W.W.
Vodra, Esq.
|
| Date
of Briefing: |
December
2, 2002 |
| Approximate
length: |
One
hour |
| Description: |
Vodra,
one of the foremost authorities on FDA laws and regulations,
provides practical
information on what actions to take if you are presented
a warning letter or a 483 from the FDA. |
| Price: |
$195
CD |
| ttttttttttttt
|
Go
to the
Order Form |
 |
|
Page
last updated
October 16, 2006
Washington Information
Source © Copyright 2006
208 South King Street, Leesburg, VA 20175
Tel: (703) 779-8777 . Fax: (703) 779-2508
service@fdainfo.com .
www.expertbriefings.com
This site has been accessed:
times since April 7, 2003
|